epitope corresponding to amino acids 47-295 mapping at the C-terminal domain of cyclin G1 of human origin
recommended for detection of cyclin G1 and cyclin G2 of mouse, rat and human origin by WB, IP, IF and ELISA; also reactive with additional species, including equine, canine, bovine and porcine
cyclin G1/G2 Background Information Cyclins are the regulatory subunits of Cdc2 p34 and related cyclin-dependent kinases (Cdks) which play critical roles in the control of cell cycle progression. The catalytic subunit for cyclin A and B is Cdc2 p34 kinase. The Cdc2-cyclin B complex controls the G2 to M transition whereas Cdc2-cyclin A regulates S phase progression. The G1 to S transition, however, appears to be controlled by the G1 cyclins. cyclin D1 accumulates during G1 and associates with Cdk2, Cdk4 and Cdk5. cyclin E and Cdk2 interact during the G1 to S transition. cyclin G contains a typical N terminal cyclin box and a carboxy-terminal domain sequence homologous to the tyrosine phosphorylation site of the epidermal growth factor receptor. cyclin G expression is induced within 3 hours after growth stimulation and remains elevated with no apparent cell cycle dependency. cyclin G2 shares 53% amino acid sequence identity with cyclin G1. Peak expression of cyclin G2 is seen in late S phase, as opposed to cyclin G1 expression, which is constitutive.
cyclin G1/G2 (FL-249) Product Citations
See how others have used cyclin G1/G2 (FL-249): sc-851 antibody and or cyclin G1/G2 (FL-249) antibody conjugates.